The Company confirms that its trading performance to date and expectations for 2019 are in line with the guidance provided in its 7 June 2019 trading update. Accordingly, the Company expectation to deliver 2019 revenues of approximately US $87m, EBITDA of approximately US $28m, and expects to have net cash at 31 December 2019 of approximately US $18m remains unchanged.
Back to All News
All Market News
Other Market News
Advanced Medical Solutions Release Statement Regarding Possible Offer
Renishaw – Trading Statement
Pepsi Publish Q1 2026 Results
B.P. Marsh – Deferred Consideration Receipt & Special Dividend
LondonMetric Property – Trading Update
Conccurent Technologies – Final Results
Sign up for our Stock News Highlights
Delivered to your inbox every Friday